Safety Study of Subclavian and Internal Jugular Venous Catheterization

E-DA Hospital

Status: Unknown

Conditions: Rates of Complications; Time to Insertion

Treatments: Device: Central venous catheter

Study type: Interventional

Funder types: Other

Identifiers

NCT01196962

EDAH (Other Identifier)

CSIS

Details and patient eligibility

About

There is no randomized controlled trial to compare the rates of complications associated with internal jugular and subclavian venous catheterization. The aim of this study is to compare mechanical, infectious, and thrombotic complications of internal jugular and subclavian venous catheterization. An improved understanding of CVC-related risks might help clinicians to choose one approach over the other in specific clinical settings.

Full description

Central venous catheterization is often necessary to treat critically ill patients hospitalized in intensive care units (ICUs). However, this procedure may lead to serious and sometimes life-threatening complications, including mechanical, infectious, or thrombotic complications. The choice of insertion site can influence the incidence and type of such complications. The most frequently used sites for CVC insertion are the internal jugular and the subclavian vein. However, in an individual patient, criteria for choosing one approach over the other remain unclear.

Enrollment: 300 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• admission to ICU
• requiring central venous catheterization
• without contraindications to attempt both jugular and internal jugular access

Exclusion criteria

• the presence of a central venous catheter at admission
• central venous catheterization within 2 weeks prior to admission
• emergency catheterization for a life-threatening situation
• major blood coagulation disorders
• anatomic defect precluding catheterization at either site
• skin lesions or recent surgery at either site

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

300 participants in 1 patient group

Internal jugular vein

Experimental group

Treatment:

Device: Central venous catheter